Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist

Journal of Medicinal Chemistry
2017.0

Abstract

The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing's syndrome. While this drug is highly effective, lack of selectivity for GR leads to unwanted side effects in some patients. Optimization of the previously described fused azadecalin series of selective GR antagonists led to the identification of CORT125134, which is currently being evaluated in a phase 2 clinical study in patients with Cushing's syndrome.

Knowledge Graph

Similar Paper

Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist
Journal of Medicinal Chemistry 2017.0
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists
Journal of Medicinal Chemistry 2015.0
Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)
Journal of Medicinal Chemistry 2019.0
Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist
Bioorganic & Medicinal Chemistry Letters 2007.0
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)
Journal of Medicinal Chemistry 2018.0
2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF<sub>1</sub>) Antagonists
Journal of Medicinal Chemistry 2009.0
Synthesis and antihormonal properties of novel 11β-benzoxazole-substituted steroids
Bioorganic &amp; Medicinal Chemistry Letters 2012.0